Literature DB >> 27665371

Evaluation of influenza vaccine-immunogenicity in cell-mediated immunity.

Naruhito Otani1, Masayuki Shima2, Takashi Ueda3, Kaoru Ichiki3, Kazuhiko Nakajima3, Yoshio Takesue3, Toshiomi Okuno4.   

Abstract

The immunological effect of influenza vaccines cannot be evaluated accurately using an antibody titer. Therefore, we used a new method that measures cell-mediated immunity to investigate changes in the amount of interferon-gamma (IFN-γ) produced after vaccination in response to the vaccine antigen. The study was conducted during the 2014-2015 influenza season in 23 adults, using a vaccine that contained three types of antigen. The IFN-γ level increased by at least 1.5 times in 65% (15/23) of cases in response to the H1N1 antigen, in 57% (13/23) of cases in response to the H3N2 antigen, and in 57% (13/23) of cases in response to the B antigen. During the study period, 4 subjects developed type A influenza. Our data showed that the IFN-γ level did not increase by 1.5 times in these subjects. We propose that the efficacy of influenza vaccines may be evaluated by measuring changes in the level of IFN-γ produced in response to influenza vaccine. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antigen; Cell-mediated immunity; Humoral immunity; Influenza; Interferon-gamma; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27665371     DOI: 10.1016/j.cellimm.2016.09.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.

Authors:  Shu-Ting Ren; Xue-Mei Zhang; Peng-Fei Sun; Li-Juan Sun; Xue Guo; Tian Tian; Jian Zhang; Qi-Yuan Guo; Xue Li; Li-Jun Guo; Jin Che; Bing Wang; Hui Zhang
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

2.  Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples.

Authors:  Naruhito Otani; Kazuhiko Nakajima; Kaori Ishikawa; Kaoru Ichiki; Yoshiko Yoda; Takashi Ueda; Yoshio Takesue; Takuma Yamamoto; Susumu Tanimura; Masayuki Shima; Toshiomi Okuno
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

3.  Changes in Cell-Mediated Immunity (IFN-γ and Granzyme B) Following Influenza Vaccination.

Authors:  Naruhito Otani; Kazuhiko Nakajima; Kaori Ishikawa; Kaoru Ichiki; Takashi Ueda; Yoshio Takesue; Takuma Yamamoto; Susumu Tanimura; Masayuki Shima; Toshiomi Okuno
Journal:  Viruses       Date:  2021-06-13       Impact factor: 5.048

4.  Common Features of Regulatory T Cell Specialization During Th1 Responses.

Authors:  Katharina Littringer; Claudia Moresi; Nikolas Rakebrandt; Xiaobei Zhou; Michelle Schorer; Tamas Dolowschiak; Florian Kirchner; Felix Rost; Christian W Keller; Donal McHugh; Salomé LeibundGut-Landmann; Mark D Robinson; Nicole Joller
Journal:  Front Immunol       Date:  2018-06-13       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.